Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1450184Generated: October 26, 2026

Sodium hydride → 11-[4-(2-Cyanobenzyl)-1-piperazinyl]dibenz[b,f][1,4]oxazepine

https://huagongshe.com/reaction/1450184

Reaction equation

Participants

RoleNameHCIDCharge
ReactantSodium hydrideHCID 24758—
Reactant2-(Bromomethyl)benzonitrileHCID 89599—
Reactant11-(Piperazin-1-yl)dibenzo(b,f)(1,4)oxazepineHCID 7061874—
SolventDimethylformamideHCID 6228—
Product11-[4-(2-Cyanobenzyl)-1-piperazinyl]dibenz[b,f][1,4]oxazepineHCID 18971342—

Reaction Conditions

Temperature0 °C

Reaction Steps

To a stirred solution of 11-(1-piperazinyl)dibenz[b,f][1,4]oxazepine (2.79 g, 10.0 mmol) (prepared from 10,11-dihydrodebenz[b,f][1,4]oxazepine-11-one, Aldrich and piperazine, as in example 1) in DMF (25 mL) was added sodium hydride (0.56 g, 60% in oil, 14 mmol) at 0° C. under argon. The mixture was stirred at 0° C. for 10 minutes at room temperature for 20 minutes, and then treated with α-bromo-o-tolunitrile (2.35 g, 12.0 mmol, Aldrich). The resulting mixture was stirred at room temperature overnight and quenched with saturated ammonium chloride solution (25 mL). The mixture was separated and extracted with ethyl acetate (3×50 mL). The combined organic phase was dried over magnesium sulfate and filtered. The filtrate was concentrated in vacuo to dryness and the residue was subjected to column chromatography using ethyl acetate:hexane (1:2) as the eluent. The title compound was obtained as a white solid (2.34 g, 59%), m.p. 136°-138° C.; MS 395 (M+ +1).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS05602120
Source datasetuspto-grants-1997_02
ORD IDord-f0875813a71c4db8a298e0f89d0c3e74
Source noteuspto-grants-1997_02